https://biotechmorning.com/news/charles-river-labs-bellwether-biotech-recovery Biotech Morning en 2026-08-16T14:16:41.421Z The Canary in Biotech's Coal Mine Just Started Singing https://biotechmorning.com/news/biomarin-270-million-phase-3-failure Biotech Morning en 2026-08-16T14:15:56.795Z BioMarin Just Lit $270 Million on Fire https://biotechmorning.com/news/capricor-stock-surge-after-fda-adcom-rejection-duchenne Biotech Morning en 2026-08-16T14:15:16.510Z The Biotech Stock That Crashed, Then Pulled a Houdini https://biotechmorning.com/news/fda-commissioner-kalvista-drug-rejection Biotech Morning en 2026-08-16T14:14:27.738Z When the FDA Commissioner Tries to Kill a Drug Himself https://biotechmorning.com/news/bms-15-billion-hengrui-china-deal-2 Biotech Morning en 2026-08-16T14:13:46.528Z BMS Just Bet $15 Billion on China's Hottest Drug Factory https://biotechmorning.com/news/tavneos-eu-withdrawal-gcp-violations Biotech Morning en 2026-08-16T14:13:00.012Z The Drug That Got Pulled Not for Being Dangerous, but for Lying https://biotechmorning.com/news/cytokinetics-sues-bristol-myers-squibb-patent-dispute Biotech Morning en 2026-08-16T14:12:18.040Z Cytokinetics Just Sued Bristol Myers Over a Drug It Helped Create https://biotechmorning.com/news/cancer-drug-worked-still-rejected-itm-fda Biotech Morning en 2026-08-16T14:11:33.918Z The Cancer Drug That Worked But Still Got Rejected https://biotechmorning.com/news/biocryst-kills-internal-drug-discovery Biotech Morning en 2026-08-15T14:18:45.457Z BioCryst Just Killed Its Own Lab. Here's Why That Might Be Brilliant. https://biotechmorning.com/news/fibrx-therapeutics-skye-redx-merger-fibrosis Biotech Morning en 2026-08-15T14:17:59.537Z Two Struggling Biotechs Just Fused Into a $125M Bet on a Disease Nobody Can Cure https://biotechmorning.com/news/epicrispr-epigenetic-editing-fshd-milestone Biotech Morning en 2026-08-15T14:17:12.926Z The Gene Therapy That Doesn't Actually Edit Your Genes https://biotechmorning.com/news/ai-designed-parkinsons-drug-clinical-trials Biotech Morning en 2026-08-15T14:16:25.296Z An AI Just Designed a Parkinson's Drug. Now It's Heading Into Humans. https://biotechmorning.com/news/zymeworks-theravance-acquisition-strategy Biotech Morning en 2026-08-15T14:15:39.811Z Zymeworks Just Bought a Lung Drug Company. The Reason Why Is Brilliant. https://biotechmorning.com/news/lilly-750m-resilience-kwikpen-glp1-manufacturing Biotech Morning en 2026-08-15T14:14:51.707Z Lilly's $750M Bet That the Real GLP-1 War Is Fought in Factories https://biotechmorning.com/news/cdc-director-erica-schwartz-confirmed Biotech Morning en 2026-08-15T14:14:05.052Z The CDC Finally Has a Boss Again. Now Comes the Hard Part. https://biotechmorning.com/news/first-orexin-drug-narcolepsy-fda-approval Biotech Morning en 2026-08-15T14:13:25.826Z The First Drug That Tackles Narcolepsy at Its Root Just Got the Green Light https://biotechmorning.com/news/moderna-mflusiva-mrna-flu-vaccine-fda-approval Biotech Morning en 2026-08-15T14:12:40.319Z Moderna Just Proved mRNA Isn't a One-Hit Wonder